ClearPoint Neuro, Inc. (CLPT) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "CLPT"
      ],
      "issuer_cik": "0001285550",
      "owner_cik": "0001721010",
      "accession_number": "0001193125-26-292932",
      "form_type": "4",
      "filing_date": "2026-07-01",
      "period_of_report": "2026-06-29",
      "issuer_name": "ClearPoint Neuro, Inc.",
      "issuer_trading_symbol": "CLPT",
      "owner_name": "BURNETT JOSEPH",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "CEO and President",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-06-29",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 20000,
      "transaction_price_per_share": 19.38,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 116842,
      "transaction_value": 387600,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."
        },
        {
          "id": "F2",
          "description": "Represents a weighted average sales price per share. The shares were sold at prices ranging from $19.15 to $19.54. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."
        }
      ]
    },
    {
      "tickers": [
        "CLPT"
      ],
      "issuer_cik": "0001285550",
      "owner_cik": "0001721010",
      "accession_number": "0001193125-26-277503",
      "form_type": "4",
      "filing_date": "2026-06-22",
      "period_of_report": "2026-06-17",
      "issuer_name": "ClearPoint Neuro, Inc.",
      "issuer_trading_symbol": "CLPT",
      "owner_name": "BURNETT JOSEPH",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "CEO and President",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-06-17",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 1843,
      "transaction_price_per_share": 17.94,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 191388,
      "transaction_value": 33063.420000000006,
      "direct_or_indirect": "I",
      "nature_of_ownership": "See Footnote",
      "footnotes": [
        {
          "id": "F1",
          "description": "The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."
        },
        {
          "id": "F3",
          "description": "Represents a weighted average sales price per share. The shares were sold at prices ranging from $17.75 to $18.08. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."
        },
        {
          "id": "F4",
          "description": "These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.